Comparison of immunization systems in Japan and the United States – What can be learned?
| Autor: | Kristen A. Feemster, Tomohiro Katsuta, Akihiko Saitoh, Charlotte A. Moser, Paul A. Offit |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Government
Economic growth General Veterinary General Immunology and Microbiology Immunization Programs Policy making Vaccination Public Health Environmental and Occupational Health Human papillomavirus vaccine Immunization (finance) United States 03 medical and health sciences 0302 clinical medicine Infectious Diseases Japan Work (electrical) 030225 pediatrics Political science Adverse Drug Reaction Reporting Systems Humans Molecular Medicine Immunization program Immunization Papillomavirus Vaccines 030212 general & internal medicine |
| Zdroj: | Vaccine. 38:7401-7408 |
| ISSN: | 0264-410X |
| DOI: | 10.1016/j.vaccine.2020.09.028 |
| Popis: | Recently, efforts have been made to fill a so-called "vaccine gap" between Japan and other countries; however, more work remains. Concerns about adverse events following immunization (AEFI) resulted in an historically passive approach to policy making in the National Immunization Program (NIP). For example, reports of AEFI following human papillomavirus vaccine (HPVV) in 2013 led the Japanese government to withdraw its proactive recommendations, resulting in a sharp drop in HPVV coverage rate to less than 1.0%. In this report, we review key historical incidents that led to the current immunization system in Japan, compare it to that in the United States, and discuss strategies for improving the Japanese immunization system. By strengthening existing policies and programs, such as National Immunization Technical Advisory Groups and AEFI reporting, compensation laws, and immunization education, the remaining vaccine gap in Japan could be filled. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect